by Andreas Kremer | Jul 1, 2022
Esch-sur-Alzette, July 1st 2022. ITTM joined the IMI EU-PEARL project. EU-PEARL brings together patients, clinicians, industry, researchers and authorities to create an open and trusted environment for knowledge sharing and science-driven debate on innovative clinical...
by Andreas Kremer | May 12, 2022
Since its foundation in 2015, ITTM has been working very closely with numerous pharmaceutical companies in the context of IMI projects. To further strengthen these fruitful interactions ITTM is joining the Innovative Medicines for Luxembourg (IML) as a partner...
by Andreas Kremer | May 10, 2022
ITTM is proud to sponsor this year’s i2b2transmart symposium at Harvard. The symposium focuses on the vision: i2b2 for data donation “by and for the people” on a national scale. The second day will be dedicated to technical workshops andworking group updates....
by Andreas Kremer | Apr 6, 2022
Recently an informative exchange between Bernhard Frühlinger (ADAM) and Andreas Kremer (ITTM) took place in Vienna regarding the importance as well as specifics of grants for startups and SMEs. The complete interview can be found here:...
by Andreas Kremer | Mar 24, 2022
ITTM is specialised in data and knowledge management and the mission of ITTM is Making Data Actionable. Recently ITTM became member of the Powered by EBRC programme. Both organisations share the same culture and corporate values: Health-related data are very sensitive...
by Andreas Kremer | Feb 15, 2022
ITTM is participating in the COST action CA202117 Converting molecular profiles of myeloid cells into biomarkers for inflammation and cancer. It’s the first Mye-InfoBank hybrid workgroup meeting in Lisbon. It will be accompanied by the second MC meeting and the...
